Clinical Trial to Investigate and Compare the Pharmacokinetic Characteristics and Safety/Tolerability After Single Administration of JLP-1207 and Soifenacin/Tamsulosin in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2016
At a glance
- Drugs Solifenacin/tamsulosin (Primary) ; Solifenacin; Tamsulosin
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Pharmacokinetics
- Sponsors Jeil Pharmaceutical
- 23 Jun 2016 Status changed from not yet recruiting to completed.
- 14 Jul 2015 New trial record